Evolving measles status and immunization policy development in six European countries

被引:9
|
作者
Vojtek, Ivo [1 ]
Larson, Heidi [2 ]
Plotkin, Stanley [3 ,4 ]
Van Damme, Pierre [5 ]
机构
[1] GSK, Ave Fleming 20, B-1300 Wavre, Belgium
[2] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England
[3] Univ Penn, Sch Med, Doylestown, PA 19104 USA
[4] Vaxconsult, Doylestown, PA USA
[5] Univ Antwerp, Vaccine & Infect Dis Inst, Ctr Evaluat Vaccinat, Antwerp, Belgium
关键词
Measles; routine immunization; decision-making; policy; VACCINATION COVERAGE; OUTBREAK; ELIMINATION; RUBELLA; GERMANY; PROGRESS; MUMPS; EPIDEMIOLOGY; COMMUNITY; CAMPAIGN;
D O I
10.1080/21645515.2022.2031776
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Developing and implementing new immunization policies in response to shifting epidemiology is a critical public health component. We adopted a mixed-methods approach (via narrative literature review [101 articles] and 9 semi-structured interviews) to evaluate policy development in response to shifting measles epidemiology in six European countries (Italy, Belgium, Germany, Romania, UK, and Ukraine); where policies and strategies have evolved in response to country-specific disease and vaccination patterns. Periodic outbreaks have occurred in all countries against a background of declining measles-containing-vaccine (MCV) uptake and increasing public vaccine hesitancy (with substantial regional or social differences in measles burden and vaccine uptake). Health-care worker (HCW) vaccine skepticism is also seen. While many outbreaks arise or involve specific susceptible populations (e.g., minority/migrant communities), the broader pattern is spread to the wider (and generally older) population; often among incompletely/non-vaccinated individuals as a legacy of previous low uptake. Immunization policy and strategic responses are influenced by political and social factors, where public mistrust contributes to vaccine hesitancy. A strong centralized immunization framework (allied with effective regional implementation and coherent political commitment) can effectively increase uptake. Mandatory vaccination has increased childhood MCV uptake in Italy, and similar benefits could be anticipated for other countries considering vaccine mandates. Although possible elsewhere, socio-political considerations render mandating impractical in other countries, where targeted immunization activities to bolster routine uptake are more important. Addressing HCW skepticism, knowledge gaps, improving access and increasing public/community engagement and education to address vaccine hesitancy/mistrust (especially in communities with specific unmet needs) is critical.
引用
收藏
页数:15
相关论文
共 50 条
  • [1] The Impacts of Measles Elimination Activities on Immunization Services and Health Systems in Six Countries
    Hanvoravongchai, Piya
    Mounier-Jack, Sandra
    Cruz, Valeria Oliveira
    Balabanova, Dina
    Biellik, Robin
    Kitaw, Yayehyirad
    Koehlmoos, Tracey
    Loureiro, Sebastiao
    Molla, Mitike
    Ha Trong Nguyen
    Ongolo-Zogo, Pierre
    Sadykova, Umeda
    Sarma, Harbandhu
    Teixeira, Maria Gloria
    Uddin, Jasim
    Dabbagh, Alya
    Griffi, Ulla Kou
    [J]. DISEASE ERADICATION IN THE 21ST CENTURY: IMPLICATIONS FOR GLOBAL HEALTH, 2011, : 235 - 254
  • [2] National immunization strategies targeting migrants in six European countries
    Giambi, C.
    Del Manso, M.
    Dalla Zuanna, T.
    Riccardo, F.
    Bella, A.
    Caporali, M.
    Baka, A.
    Jager, N. Caks
    Melillo, T.
    Mexia, R.
    Petrovic, G.
    Declich, S.
    [J]. EUROPEAN JOURNAL OF PUBLIC HEALTH, 2018, 28 : 162 - 163
  • [3] National immunization strategies targeting migrants in six European countries
    Giambi, Cristina
    Del Manso, Martina
    Dalla Zuanna, Teresa
    Riccardo, Flavia
    Bella, Antonino
    Caporali, Maria Grazia
    Baka, Agoritsa
    Caks-Jager, Nuska
    Melillo, Tanya
    Mexia, Ricardo
    Petrovic, Goranka
    Declich, Silvia
    Ali, Karam Adel
    Dente, Maria Grazia
    Lannazzo, Stefania
    Kaic, Bernard
    Napoli, Christian
    Panagiotopoulos, Takis
    Pereira, Filipa
    [J]. VACCINE, 2019, 37 (32) : 4610 - 4617
  • [4] A NATIONAL POLICY FOR MEASLES IMMUNIZATION
    COOVADIA, HM
    LOENING, WEK
    KIEPIELA, P
    HEESE, HD
    KIBEL, MA
    BEATTY, DW
    YACH, D
    ROTHBERG, AD
    WAGSTAFF, LA
    ROSEN, EU
    COHN, RJ
    MOHANLAL, D
    PETTIFOR, JM
    RODDA, JL
    HARTMAN, E
    JACOBS, DWC
    KALA, UK
    ROODE, H
    COOPER, PA
    CARTWRIGHT, JD
    [J]. SOUTH AFRICAN MEDICAL JOURNAL, 1990, 78 (03): : 168 - 169
  • [5] A NATIONAL POLICY FOR MEASLES IMMUNIZATION
    SLABBER, CF
    [J]. SOUTH AFRICAN MEDICAL JOURNAL, 1990, 78 (09): : 552 - 552
  • [6] STATUS IN FRANCE OF THE MEASLES IMMUNIZATION
    MONNET, P
    [J]. PEDIATRIE, 1981, 36 (01): : 61 - 68
  • [7] MEASLES IMMUNIZATION - CURRENT STATUS
    不详
    [J]. CLINICAL PEDIATRICS, 1966, 5 (05) : 325 - &
  • [8] CURRENT STATUS OF MEASLES IMMUNIZATION
    不详
    [J]. JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1965, 194 (11): : 1237 - &
  • [9] MEASLES IMMUNIZATION IN DEVELOPING-COUNTRIES
    OBARO, SK
    [J]. BRITISH MEDICAL JOURNAL, 1994, 308 (6925): : 411 - 412
  • [10] Impact of Measles Elimination Activities on Immunization Services and Health Systems: Findings From Six Countries
    Hanvoravongchai, P.
    Mounier-Jack, S.
    Cruz, V. Oliveira
    Balabanova, D.
    Biellik, R.
    Kitaw, Y.
    Koehlmoos, T.
    Loureiro, S.
    Molla, M.
    Nguyen, H.
    Ongolo-Zogo, P.
    Sadykova, U.
    Sarma, H.
    Teixeira, M.
    Uddin, J.
    Dabbagh, A.
    Griffiths, U. K.
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2011, 204 : S82 - S89